 |
Articles: Pharmacokinetics |
Randomized Trial and Pharmacokinetic Study of Pegfilgrastim versus Filgrastim after Dose-Intensive Chemotherapy in Young Adults and Children with Sarcomas
Clinical Cancer Research, 11/20/09
Safety Profile, Pharmacokinetics, and Pharmacodynamics of Siplizumab, A Humanized Anti-CD2 Monoclonal Antibody, in Renal Allograft Recipients
Transplantation Proceedings, 11/20/09 Physiologically-Based Pharmacokinetic Model of Mechanism-Based Inhibition of CYP3A by Clarithromycin
Drug Metabolism and Disposition, 11/20/09 Mechanistic Insight from In Silico Pharmacokinetic Experiments: Roles of P-glycoprotein, CYP3A4 Enzymes, and Microenvironments
Journal of Pharmacology and Experimental Therapeutics, 11/20/09 
Prior Articles
Pharmacokinetics and tolerability of single escalating doses of fampridine sustained-release tablets in patients with multiple sclerosis: A phase I–II, open-label trial
Clinical Therapeutics, 11/19/09 Steady-state pharmacokinetics and tolerability of orally administered fampridine sustained-Release 10-mg tablets in patients with multiple sclerosis: A 2-week, open-label, follow-up study
Clinical Therapeutics, 11/19/09 Opiate Craving and the Presence of Psychopathology
European Addiction Research, 11/18/09 Cost Effectiveness of Herpes Zoster Vaccine in Canada
PharmacoEconomics, 11/17/09 U-500 Regular Insulin: Clinical Experience and Pharmacokinetics in Obese, Severely Insulin Resistant Type 2 Diabetic Patients
Diabetes Care, 11/16/09 A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of the Novel Proteasome Inhibitor Carfilzomib (PR-171) in Patients with Hematologic Malignancies
Clinical Cancer Research, 11/16/09 Population pharmacokinetic analysis of varenicline in adult smokers
British Journal of Clinical Pharmacology, 11/16/09 Influence of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir and its active metabolite
British Journal of Clinical Pharmacology, 11/16/09 Effects of lovastatin on the pharmacokinetics of verapamil and its active metabolite, norverapamil in rats: Possible role of P-glycoprotein inhibition by lovastatin
Archives of Pharmacal Research, 11/16/09
Free full text
The role of ceramide in major depressive disorder
European Archives of Psychiatry and Clinical Neuroscience, 11/12/09 The Role of Organic Anion–Transporting Polypeptides and Their Common Genetic Variants in Mycophenolic Acid Pharmacokinetics
Clinical Pharmacology & Therapeutics, 11/10/09 Pharmacokinetic and pharmacodynamic properties of taspoglutide, a once-weekly, human GLP-1 analogue, after single-dose administration in patients with Type 2 diabetes
Diabetic Medicine, 11/09/09 Mechanistic Insight from In Silico Pharmacokinetic Experiments: Roles of P-glycoprotein, CYP3A4 Enzymes, and Microenvironments
Journal of Pharmacology and Experimental Therapeutics, 11/09/09 Safety and Pharmacokinetics of Repeat-Dose Micafungin in Young Infants
Clinical Pharmacology & Therapeutics, 11/06/09 Pharmacokinetics of a single dose of the antifungal posaconazole as oral suspension in subjects with hepatic impairment
Current Medical Research and Opinion, 11/06/09 Safety, tolerability, pharmacokinetics and pharmacodynamics of albiglutide, a long-acting GLP-1-receptor agonist, in Japanese subjects with type 2 diabetes mellitus
Current Medical Research and Opinion, 11/06/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
